日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Application of telemedicine to improve access, and quality of healthcare services in Somalia: a perspective review and policy recommendations

应用远程医疗改善索马里医疗服务的可及性和质量:视角回顾与政策建议

Garba, Bashiru; Jimale, Ali Olow

Targeted activation in localized protein environments via deep red photoredox catalysis

通过深红色光氧化还原催化在局部蛋白质环境中进行靶向激活

Nicholas Eng Soon Tay #, Keun Ah Ryu #, John L Weber, Aleksandra K Olow, David C Cabanero, David R Reichman, Rob C Oslund, Olugbeminiyi O Fadeyi, Tomislav Rovis

Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor Models

反向翻译小鼠同源肿瘤模型中抗程序性死亡受体1免疫疗法反应的分子决定因素

Georgiev, Peter; Muise, Eric S; Linn, Douglas E; Hinton, Marlene C; Wang, Yun; Cai, Mingmei; Cadzow, Louise; Wilson, Douglas C; Sukumar, Selvakumar; Caniga, Michael; Chen, Lan; Xiao, Hui; Yearley, Jennifer H; Sriram, Venkataraman; Nebozhyn, Michael; Sathe, Manjiri; Blumenschein, Wendy M; Kerr, Kimberly S; Hirsch, Heather A; Javaid, Sarah; Olow, Aleksandra K; Moy, Lily Y; Chiang, Derek Y; Loboda, Andrey; Cristescu, Razvan; Sadekova, Svetlana; Long, Brian J; McClanahan, Terrill K; Pinheiro, Elaine M

SPATA2 and CYLD inhibit T cell infiltration into colorectal cancer via regulation of IFN-γ/STAT1 axis

SPATA2 和 CYLD 通过调节 IFN-γ/STAT1 轴抑制 T 细胞浸润结直肠癌

Tze Guan Tan, Yulia Zybina, Cooper McKenna, Aleksandra Olow, Subhadra Jayaraman Rukmini, Michael Thomas Wong, Svetlana Sadekova, Alissa Chackerian, David Bauché

Toward developing a metastatic breast cancer treatment strategy that incorporates history of response to previous treatments

旨在制定一种将既往治疗反应纳入考量的转移性乳腺癌治疗策略

Olow, Aleksandra K; Veer, Laura van 't; Wolf, Denise M

LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8+ T Cells

LILRB1阻断增强双特异性T细胞衔接抗体诱导的效应CD8+ T细胞杀伤肿瘤细胞的作用

Aeryon Kim ,Chia-Jung Han ,Ian Driver ,Aleksandra Olow ,Andrew K Sewell ,Zemin Zhang ,Wenjun Ouyang ,Jackson G Egen ,Xin Yu

Correction: LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody-Induced Tumor Cell Killing by Effector CD8(+) T Cells

更正:LILRB1阻断增强双特异性T细胞衔接抗体诱导的效应CD8(+) T细胞杀伤肿瘤细胞

Kim, Aeryon; Han, Chia-Jung; Driver, Ian; Olow, Aleksandra; Sewell, Andrew K; Zhang, Zemin; Ouyang, Wenjun; Egen, Jackson G; Yu, Xin

Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways

通过联合靶向 MAPK 和 PI3K/mTOR 信号通路克服致癌 BRAF 基因融合单药治疗的耐药性

Payal Jain, Amanda Silva, Harry J Han, Shih-Shan Lang, Yuankun Zhu, Katie Boucher, Tiffany E Smith, Aesha Vakil, Patrick Diviney, Namrata Choudhari, Pichai Raman, Christine M Busch, Tim Delaney, Xiaodong Yang, Aleksandra K Olow, Sabine Mueller, Daphne Haas-Kogan, Elizabeth Fox, Phillip B Storm, Adam

BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas

BRAF状态在儿童胶质瘤个体化治疗方案制定中的作用

Olow, Aleksandra; Mueller, Sabine; Yang, Xiaodong; Hashizume, Rintaro; Meyerowitz, Justin; Weiss, William; Resnick, Adam C; Waanders, Angela J; Stalpers, Lukas J A; Berger, Mitchel S; Gupta, Nalin; James, C David; Petritsch, Claudia K; Haas-Kogan, Daphne A

Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma

在BRAF V600E突变型胶质瘤中,BRAF抑制剂联合放射治疗可提高生存率

Dasgupta, Tina; Olow, Aleksandra K; Yang, Xiaodong; Hashizume, Rintaro; Nicolaides, Theodore P; Tom, Maxwell; Aoki, Yasuyuki; Berger, Mitchel S; Weiss, William A; Stalpers, Lukas J A; Prados, Michael; James, C David; Mueller, Sabine; Haas-Kogan, Daphne A